BRCA1 and neoplasm: Although this phenotype, broadly termed BRCAness, is most commonly associated with germline mutations in BRCA1/2, evidence from basic and clinical studies suggest that other genetic and epigenetic alterations may have similar effects on cancer risk, tumor molecular features, and drug sensitivity45.